TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Palette Life Sciences AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
61,859
|
338,969
|
185,071 |
| Financial expenses |
40,071
|
38,212
|
13,423 |
| Earnings before taxes |
-345,862
|
-307,836
|
-220,050 |
| EBITDA |
-340,035
|
-267,808
|
-204,919 |
| Total assets |
891,841
|
353,971
|
188,598 |
| Current assets |
78,770
|
243,569
|
179,866 |
| Current liabilities |
459,119
|
226,453
|
43,702 |
| Equity capital |
432,722
|
-134,226
|
54,160 |
| - share capital |
3,128
|
2,921
|
2,626 |
| Employees (average) |
2
|
84
|
49 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
48.5%
|
-37.9%
|
28.7% |
| Turnover per employee |
30,930
|
4,035
|
3,777 |
| Profit as a percentage of turnover |
-559.1%
|
-90.8%
|
-118.9% |
| Return on assets (ROA) |
-34.3%
|
-76.2%
|
-109.6% |
| Current ratio |
17.2%
|
107.6%
|
411.6% |
| Return on equity (ROE) |
-79.9%
|
229.3%
|
-406.3% |
| Change turnover | |||
| Change turnover % | 89% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % | 71% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.